What are the emerging therapeutic targets in cancer?
Recent advances in understanding the molecular and cellular mechanisms of cancer have led to the identification of new therapeutic targets. Targeted therapies, such as tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors, have shown promise in treating specific cancers. For example, inhibitors of the BRAF V600E mutation have been effective in treating melanoma, while PD-1/PD-L1 inhibitors are revolutionizing the treatment of various cancers by enhancing the immune response against tumor cells.
